Skip to main content
Erschienen in: Drugs 4/2000

01.04.2000 | Adis New Drug Profile

Racecadotril

A Viewpoint by Herbert L. DuPont

verfasst von: Herbert L. DuPont

Erschienen in: Drugs | Ausgabe 4/2000

Einloggen, um Zugang zu erhalten

Excerpt

One of the great advancements in medical care has been the development of oral rehydration treatment (ORT) for the management of dehydrating diarrhoea. When properly used, ORT has reduced fatalities among children with diarrhoea in developing countries. ORT remains the mainstay of therapy for infants and children in developing countries, in any patient with the dehydrating form of diarrhoea and for all elderly patients with diarrhoea. Symptomatic therapy is an important addition to ORT for the treatment of older children and adults with nondehydrating, nondysenteric (non-bloody) diarrhoea, particularly in industrialised countries where lethal effects of diarrhoea (outside the elderly or immunocompromised) are unusual. These drugs can be used to return patients sooner to work or to school and they may improve the quality of life while on business or leisure trips. …
Literatur
1.
Zurück zum Zitat Silberschmidt G, Schick MT, Steffen R, et al. Treatment of travellers’ diarrhoea: zaldaride compared with loperamide and placebo. Euro J Gastroenterol Hepatol 1995; 7: 871–5 Silberschmidt G, Schick MT, Steffen R, et al. Treatment of travellers’ diarrhoea: zaldaride compared with loperamide and placebo. Euro J Gastroenterol Hepatol 1995; 7: 871–5
2.
Zurück zum Zitat Dicesare D, DuPont HL, Mathewsson JJ, et al. A double-blind, randomised, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhoea among travellers to Mexico and Jamaica [abstract no. 32]. Infectious Diseases Society of America, 36th Annual Meeting; 1998 Nov 13; Denver (CO) Dicesare D, DuPont HL, Mathewsson JJ, et al. A double-blind, randomised, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhoea among travellers to Mexico and Jamaica [abstract no. 32]. Infectious Diseases Society of America, 36th Annual Meeting; 1998 Nov 13; Denver (CO)
Metadaten
Titel
Racecadotril
A Viewpoint by Herbert L. DuPont
verfasst von
Herbert L. DuPont
Publikationsdatum
01.04.2000
Verlag
Springer International Publishing
Erschienen in
Drugs / Ausgabe 4/2000
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200059040-00012

Weitere Artikel der Ausgabe 4/2000

Drugs 4/2000 Zur Ausgabe

Adis New Drug Profile

Racecadotril

Adis Drug Evaluation

Montelukast

Adis New Drug Profile

Racecadotril

Adis Drug Evaluation

Valaciclovir